NME1 and melanoma: NM23 deficiency only impacted the metastatic phenotype and not primary tumor growth (i.e. incidence and melanoma onset), suggesting effects of NM23-dependent genomic instability may be selectively directed to metastasis-driving and not tumor-driving mutations.